Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous oxytocin injection during the third stage of labor
IRCT20110103005534N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jul 2022
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxytocin in childbirth (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Blood pressure before and after delivery, Hemoglobin change and 6 more. Started Jul 2022; status: completed.
02
Drugs
oxytocin
03
Conditions
childbirth
Beyond the preview
Go deeper on IRCT20110103005534N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110103005534N2.